Vivo Capital, fka Vivo Ventures, is a life-sciences focused venture capital firm formed in 1996 with over $650M under management. The majority of Vivo's investments are in U.S. based companies with therapeutic products in clinical development. Its c...Show all
Phone: 650-688-0818
575 High Street
Suite 201
Palo Alto, 94301
California, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-06-20 | Cerebral Therapeutics | Series A | $3M | Granite Point Capital |
| 2018-06-06 | Metacrine | Series C | $65M | Alexandria Venture Investments, ARCH Venture Partners, ArrowMark Partners, Deerfield Management, Franklin Templeton Investments, Invus Group, Lilly Asia Ventures, New Enterprise Associates, Polaris Partners, venBIO, and Venrock |
| 2018-05-14 | MEI Pharma | PIPE | $75M | Amzak Capital Management, Boxer Capital, BVF Partners, CAM Capital, New Enterprise Associates, Perceptive Advisors, and Undisclosed Investors |
| 2018-04-03 | Poseida Therapeutics | Series B | $30.5M | Longitude Capital, Malin Corporation, and Tavistock Group |
| 2018-02-23 | Crinetics Pharmaceuticals | Series B | $63.5M | 5AM Ventures, OrbiMed Advisors, Perceptive Advisors, RA Capital Management, and Versant Ventures |
